跳至主要内容
临床试验/NCT06678737
NCT06678737
招募中
2 期

CBIT+TMS R33 Phase

University of Minnesota1 个研究点 分布在 1 个国家目标入组 60 人2025年2月27日

概览

阶段
2 期
干预措施
CBIT +cTBS
疾病 / 适应症
Tics
发起方
University of Minnesota
入组人数
60
试验地点
1
主要终点
Tic severity
状态
招募中
最后更新
19天前

概览

简要总结

Chronic tics are a disabling neuropsychiatric symptom associated with multiple child-onset mental disorders. Chronic tics affect 1-3% of youth 1 and are associated with impaired functioning, emotional and behavioral problems, physical pain, diminished quality of life, peer victimization, and a fourfold increased risk of suicide compared to the general population. Large randomized trials have demonstrated the superiority of CBIT over supportive therapy in child and adult patients. However, in these trials, only 52% of children and 38% of adults showed clinically meaningful tic improvement, meaning that 50-60% of patients do not benefit from CBIT. CBIT success relies on an ability to suppress tics that many youth lack. The central aim of CBIT is to enhance voluntary tic suppression. Better tic suppression ability drives CBIT improvement 10 and predicts lower tic burden over the course of illness. During the core CBIT procedure, competing response training, patients learn to inhibit tics by engaging in a competing motor action. However, research shows that many youth lack this fundamental tic suppression ability that CBIT aspires to enhance.

This study will examine the clinical and neural effects of a treatment combining Comprehensive Behavioral Intervention for Tics (CBIT) and transcranial magnetic stimulation (TMS) to the supplementary motor area (SMA) in young people with tic disorder.

注册库
clinicaltrials.gov
开始日期
2025年2月27日
结束日期
2030年7月15日
最后更新
19天前
研究类型
Interventional
研究设计
Parallel
性别
All

研究者

责任方
Sponsor

入排标准

入选标准

  • Age 12-21 years at time of enrollment.
  • Current chronic motor and/or vocal tics, defined as tics for at least 1 year without a tic-free period of more than 3 consecutive months. Tics must not be due to a medical condition or the direct physiological effects of a substance.
  • At least moderate tic severity, defined as a Yale Global Tic Severity Scale total score ≥14 (≥9 for those with motor or vocal tics only).
  • Full scale IQ greater than
  • Child, consenting parent, and adult participant required to have English fluency and literacy to ensure comprehension of study measures and instructions.
  • To increase external validity of findings, we will include participants taking psychotropic medications that have been stable for 6 weeks and expect to remain stable for the approximately 3-week intervention protocol (with the exception of those taking neuroleptic/antipsychotic medications). Those who previously received tic-specific therapy will be included if they meet the tic severity criterion.
  • Youth receiving other forms of psychotherapy will be included provided these treatments are not focused on tics. All concurrent treatments will be monitored during the study period.

排除标准

  • Medical conditions contraindicated or associated with altered TMS risk profile, including history of intracranial pathology, epilepsy or seizure disorders, traumatic brain injury, brain tumor, stroke, implanted medical devices or metallic objects in the head, current pregnancy or girls of childbearing age not using effective contraception, or any other medical condition deemed serious or contraindicated by a study physician.
  • Inability to undergo MRI (e.g., metal in body, claustrophobia, orthodontia)
  • Active suicidality.
  • Previous diagnosis of psychosis or cognitive disability.
  • Substance abuse or dependence within the past year.
  • Concurrent psychotherapy focused on tics.
  • Neuroleptic/antipsychotic medications.
  • Pregnant according to the medical history or a urine pregnancy test; and menstruating individuals capable of becoming pregnant and not using a highly effective form of contraception (FDA-approved hormonal contraceptive, IUD, tubal ligation)
  • Taking a medication that has not reached stability criterion (same medication and dose for 6 weeks with no planned changes over the intervention period)

研究组 & 干预措施

Experimental group

Youth with chronic tics randomized to a combined treatment involving Comprehensive Behavioral Intervention for Tics (CBIT) and inhibition of the supplementary motor area (SMA) using transcranial magnetic stimulation (TMS). TMS involves theta burst stimulation (cTBS).

干预措施: CBIT +cTBS

Control group

Youth with chronic tics randomized to CBIT and sham stimulation for TMS

干预措施: CBIT +sham cTBS

结局指标

主要结局

Tic severity

时间窗: pretreatment, 10days, 1,3,6 months

Yale Global Tic Severity Scale, YGTSS: Gold-standard, clinician-administered tic severity scale. Includes symptom checklist of specific tic types.

Tic Suppression Task

时间窗: pretreatment, 10days, 1,3,6 months

Direct observation measure of tic suppression ability. In this paradigm, a participant is seated alone in a room in front of a computer capturing a video recording of tic occurrences for later coding by independent raters. TST will consist of two 3-min conditions: 1) free-to-tic (FT): youth is instructed to stay seated and tic freely, a measure of naturally occurring tic frequency (tics per minute); 2) suppression: youth is instructed to suppress tics. Videos will be coded to establish tic frequencies using a computerized behavioral coding program.

Tic symptoms severity

时间窗: pretreatment, 10days, 1,3,6 months

Parent/Adult Tic Questionnaire : Adult-self or parent-report measure of tic symptoms and severity

Premonitory Urge for Tics Scale

时间窗: pretreatment, 10days, 1,3,6 months

Self-report measure of intensity of urges to tic

Emotional and Behavioral functioning

时间窗: pretreatment, 3,6 months

Child/Adult Behavior Checklist: Parent- or adult-self report measuring broad emotional and behavioral functioning

Self- and parent measure of functional impairment

时间窗: pretreatment, 10days, 1,3,6 months

Patient-Reported Outcomes Measurement Information System (PROMIS-49)

Behavior Rating Inventory of Executive Function

时间窗: pretreatment, 1,3,6 months

Self- and parent-rated measure of impairment of executive function. Raw scores are converted into standardized T-scores with a mean of 50 and standard deviation of 10, higher scores reflect greater symptom severity.

研究点 (1)

Loading locations...

相似试验